Nitto Avecia

Nitto Avecia is owned by Nitto Denko.

Nitto Denko is one of the...

• Forbes Global 2000 (#1664);
• Nikkei 225;
• Topix.

Nitto Denko is a company listed under the stock ticker 6988 (JP).

Nitto Denko has a direct presence in 6 countries.

Nitto Denko has 5 subsidiaries including Nitto Avecia, Nitto Denko Australia and Nitto Denko Czech.

They are in:

• Semiconductors83%
• Biotechnology17%

View the org chart displaying its 7 main executives

Most searched biographies at Nitto Avecia

• Seiji Fujioka, President
• Robert Conlin, General Manager, Ohio
• Paul Van Norman, General Manager, Massachusetts

Popular executive movements at Nitto Avecia

• Tammy Cooper who is Vice President, Business Development and Project Management, will be promoted to President on Jun. 21, 2024  (posted on May 5 2024).

Create your alert
to follow the executive moves at Nitto Avecia.

Nitto Denko has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nitto Avecia

Social media about Nitto Avecia

• Nitto Avecia on Wikipedia, Google News & Yahoo Finance
• Nitto Avecia on LinkedIn, Twitter & YouTube

Contact by email its executives including Tammy Cooper

Call Nitto Avecia at +1 508...

View the org chart

Register to receive your alert

Report an error